Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 970 across all filing types
Latest filing 2021-12-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于变更医疗器械生产许可证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of a medical device production license by the company 烟台正海生物科技股份有限公司. It details the updated license information, including the new product added to the production scope and the issuing authority. The document is short (948 characters) and serves as a formal notification of a regulatory change rather than a financial report or detailed management discussion. It does not contain financial data, earnings, or management changes. It is not a report publication announcement but a regulatory announcement about a license change. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-12-29 Chinese
关于公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement about obtaining a medical device registration certificate from a regulatory authority (Shandong Province Drug Administration). It details the product information, registration certificate number, validity period, and the impact on the company. The document is short (1455 characters) and serves as an official announcement of a regulatory approval event rather than a financial report or detailed operational report. It does not contain financial data, management discussion, or regulatory filings related to financial performance. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-12-12 Chinese
关于取得医疗器械注册变更文件的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company obtaining a medical device registration change document issued by a regulatory authority (国家药品监督管理局). It details the change in product registration certificate for a medical device, including changes in product specifications and technical requirements. The document explicitly states it is an announcement (公告) about obtaining the registration change document and discusses the impact on the company. The document length is short (791 characters), and it does not contain financial statements or detailed financial data. It is not a full report but an announcement of a regulatory approval/change. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-12-07 Chinese
关于控股股东、实际控制人及其一致行动人减持股份的预披露公告
Major Shareholding Notification Classification · 95% confidence The document is a pre-disclosure announcement regarding the planned reduction of shares held by the controlling shareholder, actual controller, and their concerted parties. It details the shareholders' identities, the number and percentage of shares to be reduced, the reasons for reduction, the method and timing of the reduction, and related regulatory compliance information. The document is titled as a 'pre-disclosure announcement' and contains no financial statements or financial performance data. It is a regulatory announcement about insider shareholding changes, specifically a planned share reduction by major shareholders. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document length is 4161 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is MRQ with high confidence.
2021-12-03 Chinese
关于公司医疗器械注册进展的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the progress of a medical device registration by the company. It details the submission of supplementary materials to the National Medical Products Administration and the current status of the product registration process. The document does not contain financial data, financial statements, or detailed financial analysis. It is a regulatory update about product registration progress, not a financial report or earnings release. The document length is short (1459 characters) and it serves as an official announcement of a regulatory process update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-29 Chinese
关于控股股东、实际控制人的一致行动人股份减持计划期限届满的公告
Transaction in Own Shares Classification · 95% confidence The document is titled '减持计划期限届满公告' which translates to 'Announcement of Expiry of Share Reduction Plan Period'. It details the completion of a share reduction plan by a major shareholder, including specifics on the number of shares reduced, dates, and compliance with regulatory requirements. The content focuses on the shareholder's reduction of shares and related disclosures, not on financial results, management changes, or other report types. The document length is 1936 characters, relatively short and focused on a specific shareholder transaction. This fits the definition of a 'Transaction in Own Shares' (POS) filing, which covers company share buybacks or sales by major shareholders. Therefore, the appropriate classification is POS with high confidence.
2021-11-19 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.